This Special Issue covers many important aspects of thrombosis, but there are still areas that need more research to improve patient care. One growing area of interest is how the gut microbiome might influence clotting risk. Some studies suggest that gut bacteria and their byproducts can affect inflammation, platelet activity, and blood vessel health, but we still don’t fully understand how this plays into different thrombotic disorders. Another key topic is the role of sex differences in thrombosis—hormonal influences, pregnancy-related clotting risks, and differences in how men and women respond to anticoagulants all need further study.

Cancer-associated thrombosis is already included in this issue, but there’s still a lot to learn about how new cancer treatments like immune checkpoint inhibitors or CAR-T therapy affect clotting risk. Another emerging field is thromboinflammation, where the immune system and blood clotting interact—things like neutrophil extracellular traps (NETosis) play a role in both acute and chronic clotting disorders, but we don’t fully understand the mechanisms yet.

In cardiovascular thrombosis, subclinical or “silent” clotting is an area that needs more attention. Small clots in the microvasculature, plaque erosion, and embolization can contribute to heart attacks and strokes without obvious symptoms. Finding better ways to detect and prevent these events early could improve outcomes. There’s also growing interest in using artificial intelligence and machine learning to predict clotting risk and personalize anticoagulation strategies, but this needs more real-world validation.

Finally, we’ve learned a lot about thrombosis in infectious diseases, especially after COVID-19, but there’s still much to explore. How do different infections, both viral and bacterial, contribute to clotting disorders in the long run? What are the long-term vascular effects of post-viral thrombosis? Answering these questions with more research could help refine treatments and prevention strategies. If students are looking for research topics, these areas could provide exciting opportunities to make meaningful contributions.

Dear Dr. Todor,

Hello!

Thank you for your cooperation and enlist "Thrombotic Risk and Its Management Across Diverse Clinical Settings" to share this valuable academic platform. As researchers in scientific research institutions, my team and I have long paid attention to many fields such as natural science and social science, and the relevant research results are highly consistent with the cutting-edge views advocated by your journal.

Our team has the following strengths and looks forward to working with journals:

Rich scientific research reserves: Relying on the laboratory resources of affiliated universities, a number of papers have been accumulated to meet the publication needs of multiple topics in the journal;

Financial support guarantee: Laboratories and institutions can fully bear the APC cost of manuscripts, ensuring that research results are widely disseminated in the form of open access, which helps to enhance the influence of journals.

Do I need to communicate the research framework to you in advance in order to ensure that the topic fits the journal positioning accurately? In addition, can you provide detailed submission guidelines and format requirements?

We look forward to hearing from you and working with you to promote academic innovation in the field!

With regard to

My email ID is: [email protected]